These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6431000)
1. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor. Iwata M; Akasaki M; Ishizaka K J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes. Akasaki M; Iwata M; Ishizaka K J Immunol; 1985 Jun; 134(6):4069-77. PubMed ID: 3872909 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors. Iwata M; Huff TF; Ishizaka K J Immunol; 1984 Mar; 132(3):1286-93. PubMed ID: 6363537 [TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of human IgE-binding factors on the IgE response of rat lymphocytes. Huff TF; Jardieu P; Ishizaka K J Immunol; 1986 Feb; 136(3):955-62. PubMed ID: 3079805 [TBL] [Abstract][Full Text] [Related]
5. Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin. Ishizaka T; Iwata M; Ishizaka K J Immunol; 1985 Mar; 134(3):1880-7. PubMed ID: 2578523 [TBL] [Abstract][Full Text] [Related]
6. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation. Jardieu P; Uede T; Ishizaka K J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160 [TBL] [Abstract][Full Text] [Related]
7. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor. Jardieu P; Uede T; Ishizaka K J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response. Akasaki M; Jardieu P; Ishizaka K J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840 [TBL] [Abstract][Full Text] [Related]
9. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation. Iwata M; Adachi M; Ishizaka K J Immunol; 1988 Apr; 140(8):2534-42. PubMed ID: 3258613 [TBL] [Abstract][Full Text] [Related]
10. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation. Iwata M; Ishizaka K J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527 [TBL] [Abstract][Full Text] [Related]
11. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors. Iwata M; Katamura K; Kubo RT; Ishizaka K J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378 [TBL] [Abstract][Full Text] [Related]
12. Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme. Iwata M; Munoz JJ; Ishizaka K J Immunol; 1983 Oct; 131(4):1954-60. PubMed ID: 6555215 [TBL] [Abstract][Full Text] [Related]
13. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor. Uede T; Ishizaka K J Immunol; 1984 Jul; 133(1):359-67. PubMed ID: 6609987 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the biologic activities of IgE-binding factors. III. Switching of a T cell hybrid clone from the formation of IgE-suppressive factor to the formation of IgE-potentiating factor. Huff TF; Uede T; Iwata M; Ishizaka K J Immunol; 1983 Sep; 131(3):1090-5. PubMed ID: 6224847 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin. Uede T; Hirata F; Hirashima M; Ishizaka K J Immunol; 1983 Feb; 130(2):878-84. PubMed ID: 6600257 [TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks. Steele JK; Kuchroo VK; Kawasaki H; Jayaraman S; Iwata M; Ishizaka K; Dorf ME J Immunol; 1989 Apr; 142(7):2213-20. PubMed ID: 2466892 [TBL] [Abstract][Full Text] [Related]
17. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas. Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196 [TBL] [Abstract][Full Text] [Related]
18. Regulatory effects of human IgE-binding factors in the IgE synthesis by human and rat lymphocytes. Kisaki T; Leung DY; Jardieu P; Geha RS; Ishizaka K Eur J Immunol; 1988 Nov; 18(11):1663-70. PubMed ID: 3264529 [TBL] [Abstract][Full Text] [Related]
19. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors. Jardieu P; Akasaki M; Ishizaka K J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554 [TBL] [Abstract][Full Text] [Related]
20. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor. Ohno H; Iwata M; Katamura K; Ishizaka K Int Immunol; 1990; 2(3):257-66. PubMed ID: 2128469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]